BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 26609806)

  • 1. Circulating microparticles, protein C, free protein S and endothelial vascular markers in children with sickle cell anaemia.
    Piccin A; Murphy C; Eakins E; Kunde J; Corvetta D; Di Pierro A; Negri G; Guido M; Sainati L; Mc Mahon C; Smith OP; Murphy W
    J Extracell Vesicles; 2015; 4():28414. PubMed ID: 26609806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Observational retrospective study of vascular modulator changes during treatment in essential thrombocythemia.
    Piccin A; Steurer M; Feistritzer C; Murphy C; Eakins E; Van Schilfgaarde M; Corvetta D; Di Pierro AM; Pusceddu I; Marcheselli L; Gambato R; Langes M; Veneri D; Perbellini O; Pacquola E; Gottardi M; Gherlinzoni F; Mega A; Tauber M; Mazzoleni G; Piva E; Plebani M; Krampera M; Gastl G
    Transl Res; 2017 Jun; 184():21-34. PubMed ID: 28259616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma annexin A5 and microparticle phosphatidylserine levels are elevated in sickle cell disease and increase further during painful crisis.
    van Tits LJ; van Heerde WL; Landburg PP; Boderie MJ; Muskiet FA; Jacobs N; Duits AJ; Schnog JB
    Biochem Biophys Res Commun; 2009 Dec; 390(1):161-4. PubMed ID: 19799864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma L-Arginine in Sickle Cell Anaemia Patients in Crises and its Correlation with Markers of Severity of Disease.
    Aworanti OW; Akingbola TS; Adeomi A; Alagbe AE; Salako AO
    West Afr J Med; 2021 Apr; 38(4):366-373. PubMed ID: 33902958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of hydroxyurea therapy on intravascular hemolysis and endothelial dysfunction markers in sickle cell anemia patients.
    Chenou F; Hounkpe BW; Domingos IF; Tonassé WV; Batista THC; Santana RM; Arcanjo GDS; Alagbe AE; Araújo ADS; Lucena-Araújo AR; Bezerra MAC; Costa FF; Sonati MF; De Paula EV; Dos Santos MNN
    Ann Hematol; 2021 Nov; 100(11):2669-2676. PubMed ID: 34453189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of circulating blood and endothelial cell microparticles in sickle-cell disease.
    Kasar M; Boğa C; Yeral M; Asma S; Kozanoglu I; Ozdogu H
    J Thromb Thrombolysis; 2014; 38(2):167-75. PubMed ID: 24254379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of platelet activation in sickle cell anaemia.
    Ibanga IA
    Niger J Med; 2006; 15(2):148-50. PubMed ID: 16805172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated circulating VE-cadherin+CD144+endothelial microparticles in ischemic cerebrovascular disease.
    Li P; Qin C
    Thromb Res; 2015 Feb; 135(2):375-81. PubMed ID: 25523345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD235a (Glycophorin-A) Is the Most Predictive Value Among Different Circulating Cellular Microparticles in Thrombocytopenic Human Immunodeficiency Virus Type 1.
    El-Menshawy N; Eissa M; Farag R; Aboalyazed A
    J Clin Lab Anal; 2016 May; 30(3):235-43. PubMed ID: 25716234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in circulating endothelial microvesicles in men after myocardial infarction.
    Žėkas V; Matuzevičienė R; Karčiauskaitė D; Vitkus D; Radzevičius M; Janiulionienė A; Linkevičiūtė A; Kutkienė S; Kučinskienė Z
    Adv Med Sci; 2020 Mar; 65(1):120-126. PubMed ID: 31927269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folate levels in children with sickle cell anaemia on folic acid supplementation in steady state and crises at a tertiary hospital in Enugu, Nigeria: a prospective, comparative study.
    Nnajekwu UC; Nnajekwu CO; Onukwuli VO; Chukwu BF; Ikefuna AN; Emodi IJ
    Malawi Med J; 2022 Jun; 34(2):132-137. PubMed ID: 35991819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated procoagulant microparticles expressing endothelial and platelet markers in essential thrombocythemia.
    Trappenburg MC; van Schilfgaarde M; Marchetti M; Spronk HM; ten Cate H; Leyte A; Terpstra WE; Falanga A
    Haematologica; 2009 Jul; 94(7):911-8. PubMed ID: 19508974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydroxyurea and sickle cell anemia. Clinical utility of a myelosuppressive "switching" agent. The Multicenter Study of Hydroxyurea in Sickle Cell Anemia.
    Charache S; Barton FB; Moore RD; Terrin ML; Steinberg MH; Dover GJ; Ballas SK; McMahon RP; Castro O; Orringer EP
    Medicine (Baltimore); 1996 Nov; 75(6):300-26. PubMed ID: 8982148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma microparticles of sickle patients during crisis or taking hydroxyurea modify endothelium inflammatory properties.
    Garnier Y; Ferdinand S; Garnier M; Cita KC; Hierso R; Claes A; Connes P; Hardy-Dessources MD; Lapouméroulie C; Lemonne N; Etienne-Julan M; El Nemer W; Romana M
    Blood; 2020 Jul; 136(2):247-256. PubMed ID: 32285120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating endothelial microparticle levels predict hemodynamic severity of pulmonary hypertension.
    Amabile N; Heiss C; Real WM; Minasi P; McGlothlin D; Rame EJ; Grossman W; De Marco T; Yeghiazarians Y
    Am J Respir Crit Care Med; 2008 Jun; 177(11):1268-75. PubMed ID: 18310479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The acceleration of the propagation phase of thrombin generation in patients with steady-state sickle cell disease is associated with circulating erythrocyte-derived microparticles.
    Gerotziafas GT; Van Dreden P; Chaari M; Galea V; Khaterchi A; Lionnet F; Stankovic-Stojanovic K; Blanc-Brude O; Woodhams B; Maier-Redelsperger M; Girot R; Hatmi M; Elalamy I
    Thromb Haemost; 2012 Jun; 107(6):1044-52. PubMed ID: 22535498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adult Sickle Cell Anaemia Patients in Bone Pain Crisis have Elevated Pro-Inflammatory Cytokines.
    Alagbe AE; Olaniyi JA; Aworanti OW
    Mediterr J Hematol Infect Dis; 2018; 10(1):e2018017. PubMed ID: 29531654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased Expression of Extracellular Vesicles Is Associated With the Procoagulant State in Patients With Established Rheumatoid Arthritis.
    Stojanovic A; Veselinovic M; Zong Y; Jakovljevic V; Pruner I; Antovic A
    Front Immunol; 2021; 12():718845. PubMed ID: 34394126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated plasma levels and platelet-associated expression of the pro-thrombotic and pro-inflammatory protein, TNFSF14 (LIGHT), in sickle cell disease.
    Garrido VT; Proença-Ferreira R; Dominical VM; Traina F; Bezerra MA; de Mello MR; Colella MP; Araújo AS; Saad ST; Costa FF; Conran N
    Br J Haematol; 2012 Sep; 158(6):788-97. PubMed ID: 22775554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relevance of fibrinolytic protein (D-dimer) and fibrinopeptide A as markers of sickle cell anaemia vaso-occlusive crisis.
    Ekwere TA; Ebele U; Ekanem M; Ogunro PS
    Niger Postgrad Med J; 2014 Sep; 21(3):225-30. PubMed ID: 25331238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.